Business ❯ Pharmaceutical Industry

Investment

Research and Development Manufacturing Market Trends Market Dynamics Innovation Research Funding UK Market Market Conditions AstraZeneca Stock Market Strategic Partnerships Health Products Market Opportunities Bristol Myers Squibb Healthcare Spending US Pharma Firms International Trade Corporate Governance Sector Investment in Mexico Corporate Investment Manufacturing Facilities Merck UK Economy Foreign Investment Corporate Decisions Sanofi NHS Spending Foreign Direct Investment Pfizer Supply Chains Market Agreements U.S. Market Capital Expenditure U.S. Manufacturing Life Sciences Production Facilities Economic Policies Manufacturing Expansion Venture Capital Eli Lilly Government Support Corporate Strategy International Collaboration Agreements

Boehringer Ingelheim Transfers CT-155 Commercial Rights to Click Therapeutics With $50 Million Backing

The move positions Click to seek FDA clearance for a software therapy that targets schizophrenia’s untreated negative symptoms.

Johnson & Johnson to Build $1 Billion Cell Therapy Plant in Pennsylvania

AbbVie Strikes Trump Drug-Pricing Deal, Pledges $100 Billion, Wins 3-Year Tariff Reprieve

U.S. and U.K. Seal Three-Year Zero‑Tariff Pharma Deal Tied to Higher NHS Drug Prices

Trump Jokes About COVID After RFK Jr. Coughs at Oval Office Pfizer Event

GSK Pledges $30 Billion U.S. Investment as UK Drug-Pricing Standoff Drives Pullbacks

BMS, BioNTech Small-Cell Lung Cancer Drug Posts 76% Tumor Reduction, Advances to Phase III

AstraZeneca Pauses £200m Cambridge Plan as Merck Axes £1bn London Hub

FDA Launches PreCheck to Accelerate U.S. Drug Manufacturing Approvals